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Abstract 
Background: Glutamate carboxypeptidase II (GCPII) inactivates the peptide co-transmitter N-acetylaspartylgluta-
mate following synaptic release. Inhibition of GCPII elevates extracellular levels of the peptide, inhibits glutamate 
release and is neuroprotective in an animal model of traumatic brain injury. GCPII gene knockout mice were used to 
examine the cellular mechanisms underlying the neuroprotective efficacy of this transmitter system.
Results: Following controlled cortical impact injury, GCPII knockout (KO) mice exhibited reduced TUNEL-positive 
nuclei in the contusion margin of the cerebral cortex relative to wild type mice. Impact injury reduced glutathione 
levels and superoxide dismutase and glutathione peroxidase activities and increased malondialdehyde. Each of these 
effects was moderated in KO mice relative to wild type. Similarly, the injury-induced increases in cleaved caspase-3, 
cytosolic cytochrome c levels and Bcl-2/Bax ratio observed in wild type mice were attenuated in the knockout mice.
Conclusions: These data support the hypothesis that the neuroprotective efficacy of GCPII KO in traumatic brain 
injury is mediated via a reduction in oxidative stress.
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Background
Traumatic brain injury (TBI) results in immediate irre-
versible primary brain tissue damage and secondary 
delayed loss of neurons and glia in the penumbra sur-
rounding the injury site leading to progressive emotional, 
cognitive and behavioral impairment [1]. Prevention of 
the secondary brain injury represents the main target of 
TBI therapy. Excessive release of glutamate following TBI 
and subsequent intracellular calcium (Ca2+) overload sig-
nificantly contributes to second brain injury, including 
brain edema, cerebral ischemia, energy failure, mitochon-
drial dysfunction, abnormal oxidative phosphorylation, 
and neuronal death [2]. Notably, glutamate accumulation 
inhibits cystine uptake and leads to depletion of GSH, a 
crucial constituent of the anti-oxidative system [3]. Ele-
vated intracellular Ca2+ makes neurons more dependent 
on cystine uptake for GSH synthesis, thus exacerbates 
the imbalanced redox status. Neuronal degeneration fol-
lowing excess glutamate exposure also has been attrib-
uted to oxidative damage generated in mitochondria 
[4]. Mitochondrial dysfunction induced by TBI causes 
overproduction of reactive oxygen species, depletion of 
adenosine triphosphate, and more importantly, leakage 
of cytochrome c, which is a key mediator in prompting 
caspase-dependent cell apoptosis [5]. As a result, inhibi-
tion of glutamate release following TBI is likely to attenu-
ate oxidative stress and delayed cell death.
N-Acetylaspartylglutamate (NAAG) is one of the 
most abundant transmitters in the mammalian nervous 
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system [6], and serves as a potent agonist at the type 3 
metabotropic glutamate receptor (mGluR3) [7–9]. Acti-
vating mGluR3 by NAAG reduces the synaptic glutamate 
release [10–12]. Furthermore, elevated concentration 
of NAAG promotes glutamate uptake in astrocytes as a 
consequence of mGluR3 activation [13, 14]. Inhibition of 
glutamate carboxypeptidase II (GCPII) increased NAAG 
and reduced glutamate, aspartate, and GABA levels in a 
fluid percussion injury rat model [15]. In the same TBI 
model system, NAAG peptidase inhibition, reduced 
acute neuronal degeneration and astrocyte damage in the 
CA2/3 regions of the hippocampus [16].
These data suggest that inhibition of GCPII is a poten-
tially significant therapeutic strategy for reducing gluta-
mate induced secondary neurodegeneration following 
traumatic brain injury. However, the cellular mecha-
nisms underlying this neuroprotection have not been 
established. In the present study, a GCPII knockout (KO) 
mouse strain has been used to assess the potential role 
of oxidative stress related pathways in the neuroprotec-
tive activity of NAAG. We previously reported that these 
GCPII KO mice develop normally and exhibit less neu-
rodegeneration and astrocyte damage following TBI [17].
Methods
Animals
Male GCPII KO mice and their littermates (from the 
Shanghai Research Center for Model Organisms, China) 
in ages 8–12 weeks, weighing 25–28 g were used in this 
study. Genotypes of KO mice and their wild-type (WT) 
littermates were confirmed by PCR amplification as 
described in a previous study [17]. Animals were free 
access to food and water and housed under a 12-h light/
dark cycle in a constant temperature (24 °C) and humid-
ity (50 %) environment.
Production of TBI
A controlled cortical impact (CCI) device (PinPoint™ 
PCI3000, Hatteras Instruments Inc., USA) was used 
to induce TBI as described previously [17]. Mice were 
anesthetized (sodium pentobarbital, 65  mg/kg intra-
peritoneally) and fixed in a stereotaxic frame. The core 
body temperature was monitored by a rectal probe 
and maintained at 37.0 ±  0.3  °C using a heating pad. A 
5-mm diameter craniotomy centered at 2.0  mm poste-
rior to bregma and 2.0 mm lateral to the midline over the 
right parietal cortex was performed, and injury to dura 
was avoided. Injury was induced by a 3.0  mm rounded 
metal tip that was angled to have a vertical direction to 
the brain surface. The metal tip compressed the brain at 
a speed of 3.0 m/s with a deformation depth of 1.0 mm 
below the dura. Apart from CCI injury, the sham group 
mice underwent the identical procedure as injured mice.
Tissue collecting and sectioning
Animals (n = 6 per group) were euthanized with sodium 
pentobarbital (65  mg/kg intraperitoneally) at 24  h post-
injury, and transcardially perfused with phosphate-buffered 
saline (PBS) followed by 50  ml of 4  % paraformaldehyde 
(PFA). The intact brains were post-fixed in 4 % PFA at 4 °C 
overnight and then transferred to PBS containing 30  % 
sucrose for cytoprotection. Consecutive coronal sections of 
5 μm thickness were cut at 200 μm intervals in a vibratome 
(Leica VT 1000S). Every section starting at approximately 
bregma-1 mm and ending at bregma-3.5 mm was collected 
in 24-well cell culture plate for staining. A total number of 
twelve sections in each brain were collected for terminal 
deoxynucleotidyltransferase-mediated dUTP nick 30′-end 
labeling (TUNEL) staining.
TUNEL staining and quantification
TUNEL staining data were obtained using a commercial 
kit (In situ Cell Death Detection Kit; Roche Molecular 
Biochemicals, Mannheim, Germany). Briefly, sections 
were incubated in TUNEL reaction mixture contain-
ing terminal deoxynucleotidyltransferase (TDT) for 
60  min at 37  °C. The slides were then washed in PBS 
for three times, counterstained with 4′,6-diamidino-
2-phenylindole (DAPI) for 2 min, and rinsed with PBS. 
The sections were analyzed under a fluorescent micro-
scope (20× objective, Nikon 90i, Tokyo). A cell was 
considered as apoptotic only if its nucleus was stained 
with both fluorescein and DAPI. Six randomly selected 
non-overlapped vision fields (at 200× magnification) 
surrounding the primary contused area in each section 
(n = 6 per group) were chosen, and the mean number of 
TUNEL-positive nuclei/DAPI-stained nuclei in the six 
views was regarded as the apoptotic index of each sec-
tion. The final average percentage of TUNEL-positive 
cells of the twelve sections was regarded as the data for 
each animal.
Measurement of glutathione (GSH), malondialdehyde 
(MDA) levels, and superoxide dismutase (SOD) 
and glutathione peroxidase (GPx) activities
To detect oxidative damage and evaluate the neuropro-
tective ability of GCP II KO against TBI-induced oxida-
tive injury, the entire ipsilateral cortex (n = 6 per group) 
was collected 24 h following TBI for analysis of the brain 
concentration of MDA and GSH and the activity of GPx 
and SOD using commercially available assay kits (Nan-
jing Jiancheng Bioengineering Institute, Nanjing, China).
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Protein extraction and western blot analysis
Mice were sacrificed and decapitated 1  day after CCI, 
and the brains (n = 6 per group) were quickly removed. 
A 5-mm punch of the ipsilateral cortex including 3 mm 
primary impacted tissue and 2  mm penumbra tissue 
in each brain was obtained for western blot analysis 
(n = 6 per group). Protein extraction of both cytosolic 
and mitochondrial fractions was performed as previ-
ously described [18]. Samples were homogenized in 
prechilled extraction buffer (Cytosol/Mitochondria 
Fractionation kit; Merck, Rockland, Massachusetts, 
USA) with a protease inhibitor and DTT, and then sedi-
mented at 700  g for 10  min at 4  °C. The supernatant 
was further sedimented at 10,000 g for 30 min at 4  °C. 
Supernatant of 10,000 g was collected as cytosolic frac-
tion while the pellet was resuspended with mitochon-
drial extraction buffer mix and saved as mitochondrial 
fraction. Protein concentrations were determined using 
the Pierce BCA kit. Equal amounts (40  μg) of proteins 
were separated by 12  % sodium dodecyl sulfate–poly-
acrylamide gels and transferred to polyvinylidene fluo-
ride (PVDF) membranes. The membranes were blocked 
with 5 % skimmed milk in PBS containing 0.05 % Tween 
20 (PBST) for 2 h at room temperature and then probed 
with primary antibodies at 4 °C overnight on a shaking 
platform. The primary rabbit-anti-mouse antibodies, 
including cleaved caspase-3, cytochrome c, Bcl-2, Bax, 
β-actin, and VDAC were 1:1000 dilutions purchased 
from Cell Signaling Technology, Danvers, MA, USA. 
The membranes were washed by PBST and incubated 
with goat anti-rabbit peroxidase-conjugated second-
ary antibody (1:5000; Bioworld Technology, Minneapo-
lis, MN, USA) at 4 °C for 1.5 h. The relative intensity of 
protein signals was normalized to the corresponding 
β-actin or VDAC intensity and was analyzed by Image 
J software.
Statistical analysis
All data were presented as mean ± standard error of the 
mean (SEM). Data were analyzed by one-way ANOVA 
and post hoc Bonferroni t test. Statistical difference was 
set at p < 0.05.
Results
GCPII KO attenuates oxidative stress after traumatic brain 
impact
Decreased SOD and GPx activities, GSH level as well 
as increased MDA level were observed in the WT TBI 
group compared to the WT sham group (p  <  0.05, 
n = 6) (Fig. 1). No significant differences were observed 
between the WT and GCPII KO sham group. GCPII 
KO resulted in significantly diminished elevation 
Fig. 1 Effects of GCP II KO on GSH (a), MDA (b), SOD (c), GPx (d). TBI caused significant decreases of GSH level, SOD, GPx activities, and an increase 
in the MDA level. GCP II KO significantly moderated these changes while not altering the levels in sham controls. Data were represented as 
mean ± SEM (n = 6 per group); *p < 0.05, versus sham control of the same genotype; #p < 0.05, versus injured WT mice
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of MDA level compared to WT TBI mice (p  <  0.05, 
n  =  6). In addition, GCPII deletion produced signifi-
cant increases in GSH level, and SOD and GPx activi-
ties compared to their WT counterparts (all p  <  0.05, 
n = 6).
GCPII gene knockout reduced post‑injury cell apoptosis 
in the injured cortex
TUNEL staining was performed to assess TBI-induced 
cell apoptosis. TUNEL-positive nuclei were not observed 
in both sham TBI groups (Fig. 2). The number of apoptotic 
Fig. 2 GCP II KO inhibited TBI-induced apoptosis. a Representative TUNEL-staining (green) and DAPI-stained (blue) brain sections of the penumbra 
area at 1.4 mm from the bregma (magnification ×200). The scale bar is 100 μm. b Quantification showed that GCP II KO markedly decreased the 
apoptotic index after TBI compared to the WT TBI mice. Data were represented as mean ± SEM (n = 6 per group); *p < 0.05, versus sham control of 
the same genotype; #p < 0.05, versus injured wild-type mice
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cells in the contusion margin significantly increased in the 
TBI groups (both p < 0.05, n = 6). GCPII KO significantly 
diminished the number of TUNEL-positive nuclei in the 
cortex surrounding the injury core (p < 0.05, n = 6).
GCPII KO stabilized the mitochondrial homeostasis 
and downregulated the expression of cleaved caspase‑3
A decrease in the ratio of mitochondrial Bcl-2 to Bax is 
proposed to reflect an increase in the permeability of the 
mitochondrial membrane and cell susceptibility to an 
apoptotic stimulus. There was increased Bax levels as well 
as reduced Bcl-2 levels in the mitochondrial fractions after 
TBI (Fig.  3a). The mitochondrial Bcl-2/Bax ratio in the 
WT TBI group was significantly lower than that in the WT 
sham group (p < 0.05, n = 6, Fig. 3b). GCPII KO signifi-
cantly increased the ratio of Bcl-2/Bax in the mitochon-
dria compared to their WT counterparts (p < 0.05, n = 6, 
Fig.  3b). As an apparent result of elevated mitochondrial 
permeability, the level of cytosolic cytochrome c signifi-
cantly increased in the TBI groups (both p < 0.05, n = 6, 
Fig.  4a, c). However, the increase in the cytosolic 
cytochrome c level in the KO TBI mice was significantly 
less than that in the WT TBI mice (p < 0.05, n = 6, Fig. 4c).
Cleaved caspase-3 levels, a crucial apoptotic executor, 
were robustly upregulated in both groups after TBI (Fig. 4a, 
c), consistent with the result of TUNEL-staining. The GCPII 
KO group had significantly lower levels of cleaved caspase-3 
compared to their WT counterparts (p < 0.05, n = 6).
Discussion
Our previous study found that this strain of GCPII KO 
mice developed normally with no apparent differences 
compared with WT mice in terms of survival and stand-
ard neurological tests, but had lessened neuronal degen-
eration and astrocyte damage after TBI [17]. Data from 
the present study also indicate that the GCPII KO mice 
Fig. 3 Effects of GCPII KO on the expression of mitochondrial Bcl-2 and Bax. Representative immunoblots (a) and densitometric analysis (b) 
revealed a significant reduction in the mitochondrial Bcl-2/Bax ratio following TBI in both wild type and KO mice. The ratio in GCPII KO mice was 
significantly higher than their WT counterparts. The immunoblot data were scanned and normalized to the density of VDAC. The ratio of the nor-
malized data for the wild type/sham mice was given a value of one. Data from other groups are expressed as values relative to the value for the wild 
type/sham mice. Data were represented as mean ± SEM (n = 6 per group); *p < 0.05, versus sham control of the same genotype; #p < 0.05, versus 
injured wild-type mice
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are less sensitive to TBI in terms of apoptosis in the 
penumbra around the impact site and additionally sup-
port the hypothesis that this protection is mediated by 
limiting oxidative stress.
It has long been recognized that head trauma induces 
an excessive release of glutamate and prolonged activa-
tion of Ca2+ ion channels [19]. Previous reports have 
demonstrated a close relationship between glutamate 
excitotoxicity and oxidative damage [20–23]. High 
levels of glutamate release and increased Ca2+ influx 
induces generation of reactive oxygen species and inhi-
bition of GSH synthesis. Free radicals interact with 
unsaturated fatty acids in cell membranes to generate 
MDA, which serves as an index of lipid peroxidation 
[24]. Under normal conditions, the low levels of super-
oxide free radicals are scavenged by enzymatic or non-
enzymatic antioxidants. However, a consequence of the 
overproduction of free radicals is depletion of GSH and 
reduction in the activity of CAT, GPx, and SOD, result-
ing in cellular redox disequilibrium. These observations 
support the proposal that reducing glutamate release 
helps to attenuate intracellular Ca2+ overload and oxi-
dative stress.
Previous studies have reported that inhibition of 
GCPII exerts an endogenous protective role via increas-
ing extracellular levels of NAAG, which selectively acti-
vates the mGluR3 and subsequently prevents further 
pre-synaptic glutamate release. For example, pretreat-
ment with ZJ-43, an NAAG peptidase inhibitor, reduces 
the levels of glutamate, aspartate, and GABA following 
TBI, and protects neurons and astrocytes from undergo-
ing neurodegenerative changes [15]. However, the exact 
cellular mechanism by which GCPII inhibition is protec-
tive against TBI has not been fully elucidated. In the cur-
rent study, we focused on evaluating the injury-induced 
oxidative response using a GCPII KO model. In agree-
ment with the theory that inhibiting glutamate exposure 
helps with GSH synthesis [3], the brain concentration of 
GSH in the KO mice was significantly higher than that of 
the WT mice following traumatic impact. Furthermore, 
Fig. 4 The expression of cleaved caspase-3 and cytosolic cytochrome c. a Representative immunoblots of cleaved caspase-3 and cytosolic 
cytochrome c in the ipsilateral cortex from sham and injured mice. Optical densities were normalized to beta-actin. The ratio of the normalized data 
for the wild type/sham mice was given a value of one. Data from other groups are expressed as values relative to the value for the wild type/sham 
mice. There was a significant increase in cleaved caspase-3 (b) and cytosolic cytochrome c (c) protein levels in wild type TBI mice and a significant 
moderation of this effect the GCPII KO mice. Data were represented as mean ± SEM (n = 6 per group); *p < 0.05, versus sham control of the same 
genotype; #p < 0.05, versus injured WT mice
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the level of MDA was significantly reduced, and the 
activities of SOD and GPx were evidently enhanced due 
to GCPII KO. These data supports the hypothesis that 
the neuroprotective effects of GCPII KO can be attrib-
uted, at least in part, to limiting oxidative stress.
Mitochondria are important target organelles in the 
oxidative stress pathway and in affecting cell survival 
[25, 26]. The imbalance of mitochondrial Bcl-2 and Bax 
leads to an increased release of mitochondrial intermem-
brane space (IMS) proteins, such as cytochrome c, Smac/
DIABLO, and apoptosis inducing factors (AIF) [27]. 
Those IMS proteins aid in the activation of caspase-3 
and triggers apoptosis [5, 28]. In the present study, we 
observed decreased Bcl-2/Bax ratio, as well as increased 
cytochrome c leakage and cleaved caspase-3 expression 
in the tissues surrounding the primary injury. These data 
were consistent with the results of previous studies [18, 
29]. Importantly, loss of GCPII reduced the number of 
TUNEL-positive neuclei and alleviated the alterations 
of these apoptosis-related proteins in the penumbra sur-
rounding the primary impact area. These results sup-
port the hypothesis that GCPII KO better preserved the 
mitochondrial function and integrity, an action that likely 
contributes to decreased neurodegeneration following 
traumatic brain injury.
In addition to down-regulating presynaptic gluta-
mate release, another possible neuroprotective mech-
anism of GCP II KO is also worth noting. Recent 
in  vitro studies have shown that activating mGluR3 
helps with recovering the endogenous GSH level [30], 
reducing ROS generation, increasing free radical scav-
enge and stabilizing mitochondrial function [31]. The 
exact mechanism by which mGluR3 regulates glial cell 
survival remains to be elucidated, but stimulation of 
MAP/ERK kinase and PI3  K/Akt signaling pathway 
may underlie protective effects of mGluR3 activation 
in these cells [32, 33].
Conclusion
In conclusion, the current study confirmed that GCP 
II KO is neuroprotective against TBI induced oxida-
tive damage and cell apoptosis and that effects correlate 
with the preservation of mitochondrial integrity. Further 
research will be required to determine the relationship 
among extracellular glutamate and NAAG levels and 
intracellular calcium in the GCP II KO mice after TBI in 
order to better prove that GCPII KO exerts its neuropro-
tective effects through the action of NAAG.
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